Guang Zhi Liu

Technik-/Wissenschafts-/F&E-Leiter bei RAINMED MEDICAL LIMITED

44 Jahre

Electronic Technology

Consumer Services

Health Technology

Profil

Guang Zhi Liu is currently the Chief Technology Officer at Suzhou Rainmed Medical Technology Co., Ltd.
and Rainmed Medical Ltd.
He completed his undergraduate degree from Shandong University of Technology in 2001.

Aktive Positionen von Guang Zhi Liu

Unternehmen	Position	Beginn
RAINMED MEDICAL LIMITED	Technik-/Wissenschafts-/F&E-Leiter	10.12.2021
Suzhou Rainmed Medical Technology Co., Ltd. Suzhou Rainmed Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Suzhou Rainmed Medical Technology Co., Ltd. is a medical technology company based in Suzhou, China. The Chinese company is dedicated to creating a leading "platform-level" vascular intervention surgical robot and has launched the caFFR, caIMR, and FlashBot vascular intervention surgical robots. The company will continue to adhere to independent innovation, improve the clinical value of its products, create unmanned operating rooms, and promote precision medicine. The company was founded in 2014, and the CEOs are Yun Fei Huo and Yong Hui Lyu.	Technik-/Wissenschafts-/F&E-Leiter	01.09.2020

Alle aktiven Positionen von Guang Zhi Liu

Ausbildung von Guang Zhi Liu

Shandong University of Technology

Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Guang Zhi Liu im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
RAINMED MEDICAL LIMITED	Electronic Technology

Private Unternehmen	1
Suzhou Rainmed Medical Technology Co., Ltd. Suzhou Rainmed Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Suzhou Rainmed Medical Technology Co., Ltd. is a medical technology company based in Suzhou, China. The Chinese company is dedicated to creating a leading "platform-level" vascular intervention surgical robot and has launched the caFFR, caIMR, and FlashBot vascular intervention surgical robots. The company will continue to adhere to independent innovation, improve the clinical value of its products, create unmanned operating rooms, and promote precision medicine. The company was founded in 2014, and the CEOs are Yun Fei Huo and Yong Hui Lyu.	Health Technology